Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-01-05 @ 6:16 PM
Study NCT ID:
NCT06553456
Status:
COMPLETED
Last Update Posted:
2025-09-30
First Post:
2024-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Sponsor:
Protgen Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-14
Completion Date Type:
ACTUAL
First Submit Date:
2024-08-11
First Submit QC Date:
None
Study First Post Date:
2024-08-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-24
Last Update Post Date:
2025-09-30
Last Update Post Date Type:
ESTIMATED